dUTPase inhibitors (Medivir)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NamedUTPase inhibitors (Medivir)
Drug Alias Namedeoxyuridine triphosphate nucleotidohydrolase inhibitors (Medivir)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActiondUTP pyrophosphatase inhibitors
TargetsdUTP pyrophosphatase
Therapy Area/IndicationsMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMedivir AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedivir AB
Active IndicationsN/A
Inactive IndicationsMalaria

Other Information

ATC CodeN/A
Related LinksN/A